133 related articles for article (PubMed ID: 37247322)
1. The Efficacy of Nanoparticle Delivery to Hypoxic Solid Tumors by ciRGD Co-Administration Depends on Neuropilin-1 and Neutrophil Levels.
Izci M; Maksoudian C; Gonçalves F; Pérez Gilabert I; Rios Luci C; Bolea-Fernandez E; Vanhaecke F; Manshian BB; Soenen SJ
Adv Healthc Mater; 2023 Sep; 12(24):e2300594. PubMed ID: 37247322
[TBL] [Abstract][Full Text] [Related]
2. Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.
Jiang W; Huang Y; An Y; Kim BY
ACS Nano; 2015 Sep; 9(9):8689-96. PubMed ID: 26212564
[TBL] [Abstract][Full Text] [Related]
3. Peptosome Coadministration Improves Nanoparticle Delivery to Tumors through NRP1-Mediated Co-Endocytosis.
Xiang Z; Jiang G; Yang X; Fan D; Nan X; Li D; Hu Z; Fang Q
Biomolecules; 2019 May; 9(5):. PubMed ID: 31060320
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticle delivery to solid tumors: a multiparametric study on particle size and the tumor microenvironment.
Izci M; Maksoudian C; Gonçalves F; Aversa L; Salembier R; Sargsian A; Pérez Gilabert I; Chu T; Rios Luci C; Bolea-Fernandez E; Nittner D; Vanhaecke F; Manshian BB; Soenen SJ
J Nanobiotechnology; 2022 Dec; 20(1):518. PubMed ID: 36494816
[TBL] [Abstract][Full Text] [Related]
5. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
6. Combining two strategies to improve perfusion and drug delivery in solid tumors.
Stylianopoulos T; Jain RK
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18632-7. PubMed ID: 24167277
[TBL] [Abstract][Full Text] [Related]
7. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin.
Zhao N; Leng Q; Woodle MC; Mixson AJ
Biochem Biophys Res Commun; 2019 May; 513(1):242-247. PubMed ID: 30954222
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors.
He H; Liu C; Liu Y; Liu X; Wu Y; Fan J; Zhao L; Cao Y
Eur J Pharm Biopharm; 2019 Sep; 142():153-164. PubMed ID: 31226367
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review.
Kumari R; Sunil D; Ningthoujam RS
J Control Release; 2020 Mar; 319():135-156. PubMed ID: 31881315
[TBL] [Abstract][Full Text] [Related]
11. Tumor control by hypoxia-specific chemotargeting of iron-oxide nanoparticle - Berberine complexes in a mouse model.
Sreeja S; Krishnan Nair CK
Life Sci; 2018 Feb; 195():71-80. PubMed ID: 29289560
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery through nanoparticles in solid tumors: a mechanistic understanding.
Kashkooli FM; Rezaeian M; Soltani M
Nanomedicine (Lond); 2022 Apr; 17(10):695-716. PubMed ID: 35451315
[No Abstract] [Full Text] [Related]
14. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
15. Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
Xu J; Lee SS; Seo H; Pang L; Jun Y; Zhang RY; Zhang ZY; Kim P; Lee W; Kron SJ; Yeo Y
Small; 2018 Dec; 14(50):e1803601. PubMed ID: 30411856
[TBL] [Abstract][Full Text] [Related]
16. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
17. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect.
Podduturi VP; Magaña IB; O'Neal DP; Derosa PA
Comput Methods Programs Biomed; 2013 Oct; 112(1):58-68. PubMed ID: 23871689
[TBL] [Abstract][Full Text] [Related]
18. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
19. Strategies of engineering nanomedicines for tumor retention.
Qian X; Xu X; Wu Y; Wang J; Li J; Chen S; Wen J; Li Y; Zhang Z
J Control Release; 2022 Jun; 346():193-211. PubMed ID: 35447297
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
Bhattacharjee H; Balabathula P; Wood GC
Ther Deliv; 2010 Nov; 1(5):713-34. PubMed ID: 22833959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
